SOL-1 data show OTX-TKI extends rescue-free control in treatment-naive wet AMD, shaping AI-driven trial design and longer-interval care. Barakat opened by highlighting what makes CTS uniquely valuable ...
Learn how FDA’s interchangeable ranibizumab biosimilar may streamline injections, cut costs, and guide safe switching for retina patients. Following the FDA approval of ranibizumab-hkdz (Ranluspec; ...
Genetic testing transforms inherited eye disease care, but expert interpretation matters—learn why false negatives and new gene therapies reshape retina practice. Recently, my daughter and I rewatched ...
Findings from an 856-patient analysis suggest that evaluating GA topography beyond foveal involvement may better capture patient-reported functional impairment. Anegondi and colleagues analyzed ...
Swiss regulator backs tinlarebant for Stargardt as DRAGON phase 3 shows slower retinal atrophy, bringing first treatment closer to patients. Swissmedic, the Swiss Agency for Therapeutic Products, has ...
Aflibercept briefly reverses severe ROP in tiny preemies, yet nearly half relapse within weeks—prompting laser rescue and renewed safety questions. A new study 1 from Poland published in the Journal ...
The phase 2a study looks at retinal vascular diseases, including wet age-related macular degeneration (wet AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO). NovaBridge Biosciences ...
In the latest episode of The Retina TL;DR with Dr. Weng, host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Zacks about ONL1204, a first-in-class Fas pathway inhibitor showing promise in ...
Panelists discuss how clinicians manage suboptimal responders by focusing on stability rather than complete dryness, using multimodal approaches, and avoiding premature treatment switching. In this ...
Discover key insights from the AAO 2025 meeting, highlighting advancements in real-world data, gene therapies, multitargeting treatments, and AI in retina care. This year in retina is almost ...
Dr. Melissa Yuan discusses the impact of weight and postmenstrual age on foveal maturation in preterm infants, highlighting critical insights for neonatal care.
The Eye Care Network spoke with Sebastian Wolf, MD, PhD, and Sophie Bonnin, MD, PhD, who presented new findings from the OCS-05 phase 2 ACUITY trial. During the 2025 congress of the European Society ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results